Webinar: Prerequisites for a successful drug delivery device development program

Shl Group Webinar Prerequisites For A Successful Drug Delivery Device Program 800x480

To connect with industry experts and customers, SHL will be holding a webinar through Pharmaceutical Business Review on June 17 at 3:00PM London/10:00AM New York time on the topic of “Prerequisites for a successful drug delivery device development program.” Presenting the webinar will be Dr Thomas P Schoenknecht, executive director of business development.

This robust webinar will feature interactive functions such as live polls and Q&A, allowing the audience to connect with the presenter real-time. The responses from the audience also enable the presenter to address issues that pique the most interest amongst the group. Commenting on the webinar, Dr Schoenknecht said: “It has always been a great opportunity to be able to present to industry experts, potential and existing customers at different conferences. However, not everyone can make the trip in person. As a result, I am truly excited to have this opportunity to present via a webinar, where the attendee can join and interact with us from anywhere in the world.”

Sign up for the webinar HERE

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit www.shl.group

Media contact: info@shl-group.com


Related News